Fusion Pharmaceuticals
phase preliminary data | Fusion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
28 of 30
Similar slides by Fusion Pharmaceuticals
See diffirences between slides (animation)
Investor Presentation
August 2023
phase preliminary data | Fusion Pharmaceuticals
Related slides by other companies
Alkermes
Investor Day
March 2021
artistry in combination with case study year old ovarian cancer patient artistry part efficacy diagnosis on study tumor shrinkage high grade serous ovarian cancer status unknown status wild type platinum resistant prior treatment change in target lesions from cycle stable disease reduction cycle stable disease reduction cycle stable disease reduction line therapy duration mos best response cycle partial response reduction last dose not evaluable patient has remained on treatment for months treatment related aes manageable with no dose modifications majority aes grade and grade elevated alt and grade anemia notes continues on therapy as of march per criteria reported after the data cut off and awaiting confirmation progressive disease partial response stable disease data cut off march | Alkermes
Compass Therapeutics
Investor Presentation
February 2023
stable disease | Compass Therapeutics
9 Meters Biopharma
Investor Presentation
September 2022
vibrant phase summary of results | 9 Meters Biopharma
AstraZeneca
Investor Day
September 2022
rare disease | AstraZeneca
Other recent decks by Fusion Pharmaceuticals
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
August 2023
IPO
June 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io